Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists

Author(s):  Macklin Denise, Blackburn Paul L

Issue:  Mar/Apr 2013 - Volume 17, Number 2
View All Articles in Issue

Page(s):  100-110

Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 1
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 2
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 3
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 4
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 5
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 6
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 7
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 8
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 9
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 10
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Page 11

Download in electronic PDF format for $75

Abstract:  By educating their clients (especially prescribing physicians, nurses, and home healthcare aides) about the advantages of using needle-free devices to administer intravenous medications, compounding pharmacists can help prevent complications associated with vascular access devices and needlestick injuries. Despite state and federal efforts to reduce the incidence of sharps injuries among healthcare workers, percutaneous needle-stick injuries remain a source of emotional stress, morbidity, and possible mortality in those individuals. According to the Centers for Disease Control and Prevention, 50% or more of surveyed healthcare personnel do not report their occupational percutaneous injuries, and an estimated 385,000 sharps-related injuries occur annually among healthcare workers in hospitals alone. Because sharps injuries are associated with the transmission of more than 20 pathogens, including hepatitis B and C viruses and the human immunodeficiency virus, the potential burden of disease is great. For the intravenous administration of medications, however, devices safer than those requiring the use of needles are available, and pharmacists have a key role in educating caregivers about needle-free equipment and its use. In this article, we explain the types of intravenous needle-free devices of interest to compounding pharmacists and the clients they serve, and we answer frequently asked questions about that equipment. Compounders who understand the design features and capabilities of such products, their clients’ intended use of those devices, and patients’ specific needs can improve treatment outcomes and protect healthcare workers against needlestick injury.

Related Keywords: sharps injury, needlestick, needle-free drug injection systems, intravenous administration, solid-dose injectors, jet-injection devices, healthcare workers, catheter-related bloodstream infections, vascular access devices, intraluminal thrombotic catheter occlusions, thrombus, treatment complication, prevention, negative-displacement mechanical valve, positive-pressure mechanical valve, zero fluid displacement, neutral fluid displacement, split septum device, biofilm, bacteria, bacterial infection, IV connectors, silver

Related Categories: PARENTERALS, TECHNOLOGY, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise
, Blackburn Paul L
Mar/Apr 2013
Pg. 100-110

Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A
, Stout Richard R, Ron Marcinkoski
Jul/Aug 2013
Pg. 270-280

Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
May/Jun 2003
Pg. 170-174

A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
Mar/Apr 2014
Pg. 94-99

Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
Nov/Dec 2015
Pg. 491-500

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022
Pg. 72-79

Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal
, Rios GL Quito
Sep/Oct 2022
Pg. 358-362

Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Penoyer Daleen
, Giuliano Karen, Middleton Aurea
Mar/Apr 2023
Pg. 169-174

Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Zhang Yan-ping
, Trissel Lawrence A
Mar/Apr 1997
Pg. 132-134

Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
Mar/Apr 2023
Pg. 123-139

Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe
, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Mar/Apr 2016
Pg. 148-154

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Home Infusion: Available Vascular Access Devices and Common Therapies
Kennedy Steve
, Williams LaVonn A
May/Jun 2011
Pg. 183-188

Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020
Hecq Jean-Daniel
, Soumoy Laura
Nov/Dec 2021
Pg. 510-514

Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free
Gupta Vishnu D
Jul/Aug 2006
Pg. 318-319

Handling of Syringes and Needles
Allen Loyd V Jr
Jan/Feb 2004
Pg. 49

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021
Pg. 515-522

Return to Top